康聖環球(09960.HK)擬1250萬美元對基金進行投資
格隆匯5月23日丨康聖環球(09960.HK)發佈公吿,於2022年5月23日,公司與基金(由普通合夥人代理)訂立認購協議,據此,公司已同意以1,250萬美元的認購金額對基金進行投資,約佔所募集投資基金的4.97%。其他投資者(包括Panacea VentureHealthcare Fund II GP Company Ltd.和PanaceaVenture Healthcare Fund II CIP, L.P.也參與了該基金的投資。訂立認購協議後,公司將通過訂立有限合夥協議被接納為本基金的有限合夥人。
截至本公吿日期,基金所募集投資資金的金額約為2.5億美元,其中公司將出資1,250萬美元,約佔所募集投資資金的4.97%。基金主要投資於高增長的創新醫療健康和生命科學公司,包括但不限於中國、美國、歐洲和其他國家的製藥、生物技術和醫療設備公司。
基金投資的高增長創新醫療健康和生命科學公司是公司的重要潛在戰略合作夥伴。認購將增進公司對生物醫學領域最新發展的瞭解。特別是,認購將(i)為公司拓展和發展市場提供前瞻性指導;(ii)增加公司在國際前沿技術與優質項目探索的廣度和深度;(iii)有效提升海外合作、項目引進及技術轉化效率;及(iv)藉助基金優勢,加速推進公司國際化佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.